Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Margarita Reboredo López"'
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205
Autor:
Nieves Martinez Lago, Ana Fernández Montes, Marta Covela Rúa, Elena M. Brozos Vázquez, Juan C. De la Cámara Gómez, Jose C. Méndez Méndez, Mónica Jorge Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo Rendo, David Arias Ron, Marta Carmona Campos, Yolanda Vidal Insua, Maria L. Pellón Augusto, Paula González Villarroel, Begoña Graña Suarez, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López
Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of antiangi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4516fdfd7ed86ceeb492a6f2d08d1f56
https://doi.org/10.21203/rs.3.rs-79440/v1
https://doi.org/10.21203/rs.3.rs-79440/v1
Autor:
Nieves Martínez-Lago, Teresa Calleja Chucla, Beatriz Alonso De Castro, Rafael Varela Ponte, Cristina Reboredo Rendo, Martin Igor Gomez-Randulfe Rodriguez, Sofia Silva Diaz, Begoña Graña Suarez, Juan de la Cámara Gomez, Fernando Busto Fernández, María Mateos Salvador, Margarita Reboredo Lopez
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract We evaluated the efficacy and safety of trifluridine/tipiracil (TAS-102) plus bevacizumab in treating refractory metastatic colorectal cancer (mCRC) in a retrospective, observational study. Patients refractory or intolerant to standard thera
Externí odkaz:
https://doaj.org/article/c57ed14ff76941199d651c58407ca464
Autor:
Maria Quindós, Alberto Carral, Ovidio Fernandez Calvo, Jesús Durana, Rosario García-Campelo, Diana Dopico Vázquez, Margarita Reboredo López, José Manuel Rois Soto, Enrique Grande, Luis M. Antón-Aparicio
Publikováno v:
Anti-Cancer Drugs. 21:S13-S15
A 75-year-old-man, with a 2-month history of abdominal pain, underwent a standard diagnostic workup that included a CT scan that showed a large right renal mass and subcentimeter nodes in the right and left lung lobes. In December 2003, the patient u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df467c951321aecb10b109f9d04a0b7
https://doi.org/10.1097/01.cad.0000361530.51675.60
https://doi.org/10.1097/01.cad.0000361530.51675.60
Autor:
Rafael, López, Carlos Méndez, Méndez, Mónica Jorge, Fernández, Carlos Romero, Reinoso, Guillermo Quintero, Aldana, Mercedes Salgado, Fernández, Juan, DE LA Cámara Gómez, Margarita Reboredo, López, Manuel Ramos, Vázquez, Sonia Candamio, Folgar
Publikováno v:
Anticancer research. 33(2)
To evaluate the efficacy and safety of erlotinib plus capecitabine for metastatic pancreatic cancer.This was a multicenter, uncontrolled, phase II trial. Patients with untreated metastatic pancreatic cancer received oral capecitabine at 1,000 mg/m(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c519bf7a4740b2d96289dca2f2d412cd
https://pubmed.ncbi.nlm.nih.gov/23393373
https://pubmed.ncbi.nlm.nih.gov/23393373
Autor:
Albert Abad, Margarita Reboredo López, Fernando Rivera, Auxiliadora Gómez, Enrique Aranda, Javier Sastre, Marta Vidaurreta, Bartomeu Massuti, Manuel Gallén, Manuel Benavides, Eduardo Díaz Rubio
Publikováno v:
Clinical colorectal cancer. 12(4)
Circulating tumor cells (CTCs) and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) status were identified as prognostic factors for progression-free survival (PFS) and overall survival (OS) in patients with metastatic colorectal cancer tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece6b796f85de1e170f6084851fc097a
https://pubmed.ncbi.nlm.nih.gov/24012456
https://pubmed.ncbi.nlm.nih.gov/24012456
Autor:
Margarita Reboredo López, Luis M. Antón Aparicio, Ovidio Fernandez Calvo, Diana Dopico Vázquez
Publikováno v:
Anti-cancer drugs. 21
A 63-year-old male, ex-smoker since 2000 underwent left radical nephrectomy in June 2004 after being diagnosed with stage II, pT3bN0M0 clear cell carcinoma. In June 2006, a control CT showed a nodule in the superior lobe, on a peripheral location, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3071178781cb7c7754e0c60c9140e418
https://pubmed.ncbi.nlm.nih.gov/20110782
https://pubmed.ncbi.nlm.nih.gov/20110782
Autor:
Paloma González Santamaría, Elena Cabeza Irigoyen, Montserrat Casmitjana Abella, Marta Maia Boscá Watts, Cristiane Murta Nascimento, Hermini Manzano, Francisco Arnal Monreal, Ana Costa Alcaraz, Josep María Segura Noguera, Olga Pueyo, Alejandro Espí Macías, Sonia Pértega Díaz, Teresa Seoane Pillado, Concepción García Aranda, Catalina Vadell, Marina Pinilla, María Martín Rabadán, Alejandro Pazos, Maria de Lluc Bennasar, Manuel Valladares Ayerbes, María Antonia Sánchez Calavera, Luis González Luján, Margarita Reboredo López, Isabel Monreal Aliaga, E. Falcó, Salvador Pita Fernández, Maite Novella, Magdalena Esteva, Andrea Burón Pust, Beatriz López Calviño, Amador Ruiz Torrejón, Luis González Saez, Francesc Macià, María Ramos Montserrat, Sergio Lafita Mainz
Publikováno v:
BMC Cancer
RUC. Repositorio da Universidade da Coruña
instname
BMC Cancer, Vol 10, Iss 1, p 528 (2010)
RUC. Repositorio da Universidade da Coruña
instname
BMC Cancer, Vol 10, Iss 1, p 528 (2010)
Background: Controversy exists with regard to the impact that the different components of diagnosis delay may have on the degree of invasion and prognosis in patients with colorectal cancer. The follow-up strategies after treatment also vary consider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660c846ee62704ac85cf2d28bb93f046